Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
NEUTRISCI INTERNATIONAL INC. RELEASES UPDATE REGARDING PRODUCT LAUNCH IN CALIFORNIA
MediPharm Labs Corp
-
August 12, 2020
0
Orphan Drug Designation is Proven Path for CBD
MediPharm Labs Corp
-
August 6, 2020
0
Lexaria Bioscience Files Application with Senior U.S. Stock Exchange for Uplisting
MediPharm Labs Corp
-
July 21, 2020
0
Alernative Pharma
Home
Alernative Pharma
Alernative Pharma
MediPharm Labs Selected by University Health Network and Medical Cannabis by...
MediPharm Labs Corp
-
July 16, 2020
0
Alernative Pharma
Heart Health and COVID-19: Fighting Inflammation May be Key
Robin Lefferts
-
July 16, 2020
0
Alernative Pharma
Regulators Move to Remove Restriction on Some Uses of Psilocybin
Andrew M.
-
July 6, 2020
0
Alernative Pharma
Cardiol Therapeutics Appoints CNBC Market Analyst Steven Grasso as Business Advisor
Cardiol Therapeutics
-
June 29, 2020
0
1
2
3
Page 1 of 3
- Advertisement -
LATEST NEWS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Cardiol Therapeutics
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Cardiol Therapeutics
-
February 22, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Cardiol Therapeutics
-
December 22, 2020
Therma Bright Achieves High Accuracy Results from Feasibility Studies for Its COVID-19 Rapid Saliva...
Cardiol Therapeutics
-
December 8, 2020
LATEST INTERVIEWS